1
|
Lefrere A, Godin O, Jamain S, Dansou Y, Samalin L, Alda M, Aouizerate B, Aubin V, Rey R, Contu M, Courtet P, Dubertret C, Haffen E, Januel D, Leboyer M, Llorca PM, Marlinge E, Manchia M, Neilson S, Olié E, Paribello P, Pinna M, Polosan M, Roux P, Schwan R, Tondo L, Walter M, Tzavara E, Auzias G, Deruelle C, Etain B, Belzeaux R. Refining Criteria for a Neurodevelopmental Subphenotype of Bipolar Disorders: A FondaMental Advanced Centers of Expertise for Bipolar Disorders Study. Biol Psychiatry 2025; 97:806-815. [PMID: 39395474 DOI: 10.1016/j.biopsych.2024.09.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/22/2024] [Revised: 09/03/2024] [Accepted: 09/25/2024] [Indexed: 10/14/2024]
Abstract
BACKGROUND Bipolar disorder (BD) is a complex and heterogeneous psychiatric disorder. It has been suggested that neurodevelopmental factors contribute to the etiology of BD, but a specific neurodevelopmental phenotype (NDP) of the disorder has not been identified. Our objective was to define and characterize an NDP in BD and validate its associations with clinical outcomes, polygenic risk scores, and treatment responses. METHODS We analyzed the FondaMental Advanced Centers of Expertise for Bipolar Disorders cohort of 4468 patients with BD, a validation cohort of 101 patients with BD, and 2 independent replication datasets of 274 and 89 patients with BD. Using factor analyses, we identified a set of criteria for defining NDP. Next, we developed a scoring system for NDP load and assessed its association with prognosis, neurological soft signs, polygenic risk scores for neurodevelopmental disorders, and responses to treatment using multiple regressions, adjusted for age and gender with bootstrap replications. RESULTS Our study established an NDP in BD consisting of 9 clinical features: advanced paternal age, advanced maternal age, childhood maltreatment, attention-deficit/hyperactivity disorder, early onset of BD, early onset of substance use disorders, early onset of anxiety disorders, early onset of eating disorders, and specific learning disorders. Patients with higher NDP load showed a worse prognosis and increased neurological soft signs. Notably, these individuals exhibited a poorer response to lithium treatment. Furthermore, a significant positive correlation was observed between NDP load and polygenic risk score for attention-deficit/hyperactivity disorder, suggesting potential overlapping genetic factors or pathophysiological mechanisms between BD and attention-deficit/hyperactivity disorder. CONCLUSIONS The proposed NDP constitutes a promising clinical tool for patient stratification in BD.
Collapse
Affiliation(s)
- Antoine Lefrere
- Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France; Institut de Neurosciences de la Timone, Aix-Marseille University, Unité mixte de recherche (UMR) Centre National de la Recherche Scientifique, Marseille, France; Fondation Fondamental, Créteil, France
| | - Ophélia Godin
- Fondation Fondamental, Créteil, France; University Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale, Institut Mondor de Recherche Biomédicale, Translational Neuro-Psychiatry, Assistance Publique-Hôpitaux de Paris, Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT)
| | - Stéphane Jamain
- Fondation Fondamental, Créteil, France; University Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale, Institut Mondor de Recherche Biomédicale, Translational Neuro-Psychiatry, Assistance Publique-Hôpitaux de Paris, Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT)
| | | | - Ludovic Samalin
- Fondation Fondamental, Créteil, France; Department of Psychiatry, Centre Hospitalier Universitaire Clermont-Ferrand, University of Clermont Auvergne, Centre National de la Recherche Scientifique, Clermont Auvergne INP, Institut Pascal (UMR 6602), Clermont-Ferrand, France
| | - Martin Alda
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; National Institute of Mental Health, Klecany, Czech Republic
| | - Bruno Aouizerate
- Fondation Fondamental, Créteil, France; Centre Hospitalier Charles Perrens, Laboratoire NutriNeuro, UMR Institut National de la Recherche Agronomique (1286), Université de Bordeaux, Bordeaux, France
| | - Valérie Aubin
- Fondation Fondamental, Créteil, France; Pôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco
| | - Romain Rey
- Fondation Fondamental, Créteil, France; Bipolar Disorder Expert Centre, Le Vinatier Hospital, University Lyon, Bron, France; University Lyon 1, Institut National de la Santé et de la Recherche Médicale U1028, Centre National de la Recherche Scientifique, UMR 5292, Villeurbanne, Lyon, France; Lyon Neuroscience Research Center, Psychiatric Disorders, Neuroscience Research and Clinical Research Team, Villeurbanne, Lyon, France
| | - Martina Contu
- Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
| | - Philippe Courtet
- Fondation Fondamental, Créteil, France; Centre Hospitalier Universitaire de Montpellier, Hôpital Lapeyronie, Psychiatric Emergency and Post Emergency Department, Pole Urgence, Montpellier, France; L'Institut de Génomique Fonctionnelle, Université de Montpellier, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Montpellier, France
| | - Caroline Dubertret
- Fondation Fondamental, Créteil, France; Assistance Publique-Hôpitaux de Paris, Groupe Hospitalo-Universitaire Assistance Publique-Hôpitaux de Paris Nord, Département Médico-Universitaire de Psychiatrie et d'Addictologie ESPRIT, Service de Psychiatrie et Addictologie, Hôpital Louis Mourier, Colombes, France; Université de Paris, Institut National de la Santé et de la Recherche Médicale UMR 1266, Sorbonne Paris Cité, Faculté de Médecine, Paris, France
| | - Emmanuel Haffen
- Fondation Fondamental, Créteil, France; Service de Psychiatrie de l'Adulte, CIC-1431 Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire de Besançon, Laboratoire de Neurosciences, Université Franche Comté, Université Bourgogne Franche Comté, Besançon, France
| | - Dominique Januel
- Fondation Fondamental, Créteil, France; Unité de Recherche Clinique, Etablissement public de santé Ville-Evrard, Neuilly-sur-Marne, France
| | - Marion Leboyer
- Fondation Fondamental, Créteil, France; University Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale, Institut Mondor de Recherche Biomédicale, Translational Neuro-Psychiatry, Assistance Publique-Hôpitaux de Paris, Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT)
| | - Pierre-Michel Llorca
- Fondation Fondamental, Créteil, France; Department of Psychiatry, Centre Hospitalier Universitaire Clermont-Ferrand, University of Clermont Auvergne, Centre National de la Recherche Scientifique, Clermont Auvergne INP, Institut Pascal (UMR 6602), Clermont-Ferrand, France
| | - Emeline Marlinge
- Fondation Fondamental, Créteil, France; Le Groupe Hospitalier Universitaire Paris Nord, DMU Neurosciences, Hôpital Fernand Widal Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Mirko Manchia
- Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy
| | - Samantha Neilson
- Institut de Neurosciences de la Timone, Aix-Marseille University, Unité mixte de recherche (UMR) Centre National de la Recherche Scientifique, Marseille, France
| | - Emilie Olié
- Fondation Fondamental, Créteil, France; Centre Hospitalier Universitaire de Montpellier, Hôpital Lapeyronie, Psychiatric Emergency and Post Emergency Department, Pole Urgence, Montpellier, France; L'Institut de Génomique Fonctionnelle, Université de Montpellier, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Montpellier, France
| | | | - Marco Pinna
- Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; Lucio Bini Mood Disorder Centers, Cagliari, Italy
| | - Mircea Polosan
- Fondation Fondamental, Créteil, France; Université Grenoble Alpes, Institut National de la Santé et de la Recherche Médicale U1216, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France
| | - Paul Roux
- Fondation Fondamental, Créteil, France; Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie, Le Chesnay, France; Université Paris-Saclay, Paris, France; Université de Versailles Saint-Quentin-En-Yvelines, Versailles, France; DisAP-DevPsy-CESP, Institut National de la Santé et de la Recherche Médicale UMR 1018, Villejuif, France
| | - Raymund Schwan
- Fondation Fondamental, Créteil, France; Université de Lorraine, Centre Psychothérapique de Nancy, Institut National de la Santé et de la Recherche Médicale U1254, Nancy, France
| | - Leonardo Tondo
- Lucio Bini Mood Disorder Centers, Cagliari, Italy; International Consortium for Mood & Psychotic Disorders Research, Mailman Research Center, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
| | - Michel Walter
- Fondation Fondamental, Créteil, France; Service Hospitalo-Universitaire de Psychiatrie Générale et de Réhabilitation Psycho Sociale 29G01 et 29G02, Centre Hospitalier Régional Univertsitaire de Brest, Hôpital de Bohars, Brest, France
| | - Eleni Tzavara
- Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France; Université Paris Cité, Paris, France; Centre National de la Recherche Scientifique, UMR 8002, Paris, France
| | - Guillaume Auzias
- Institut de Neurosciences de la Timone, Aix-Marseille University, Unité mixte de recherche (UMR) Centre National de la Recherche Scientifique, Marseille, France
| | - Christine Deruelle
- Institut de Neurosciences de la Timone, Aix-Marseille University, Unité mixte de recherche (UMR) Centre National de la Recherche Scientifique, Marseille, France
| | - Bruno Etain
- Fondation Fondamental, Créteil, France; University Paris Est Créteil, Institut National de la Santé et de la Recherche Médicale, Institut Mondor de Recherche Biomédicale, Translational Neuro-Psychiatry, Assistance Publique-Hôpitaux de Paris, Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT)
| | - Raoul Belzeaux
- Fondation Fondamental, Créteil, France; Centre Hospitalier Universitaire de Montpellier, Hôpital Lapeyronie, Psychiatric Emergency and Post Emergency Department, Pole Urgence, Montpellier, France; L'Institut de Génomique Fonctionnelle, Université de Montpellier, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Montpellier, France.
| |
Collapse
|
2
|
Li K, Rodriguez KM, Zandi P, Goes FS. Who transitions to bipolar disorder? A comparison of major depressive disorder, anxiety, and ADHD. J Affect Disord 2025; 371:6-12. [PMID: 39542116 DOI: 10.1016/j.jad.2024.11.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2024] [Revised: 11/06/2024] [Accepted: 11/08/2024] [Indexed: 11/17/2024]
Abstract
BACKGROUND Diagnostic delays in Bipolar Disorder (BD) are common and may contribute to worse outcomes. While most studies focus on depression as a primary precursor, both anxiety and attention deficit disorders are also frequent initial diagnoses. In the current study, we utilized a large, diverse electronic health record (EHR) dataset to quantify the rates and correlates of conversion to BD from these major precursor diagnoses. METHODS Our study analyzed a comprehensive ten-year EHR dataset from Johns Hopkins Medicine, a diverse urban medical center, to assess and compare the rates and correlates of conversion to BD from Major Depressive Disorder (MDD), anxiety disorders, and ADHD. Risk factors for transition were assessed as time-varying variables in proportional hazards models. RESULTS Of the 21,341 patients initially included, 1232 later transitioned to a diagnosis of BD. Adjusted-one-year conversion rates for patients with MDD, anxiety disorders, and ADHD were 4.2 %, 3.4 %, and 4.0 %, respectively, with ten-year rates at 11.4 %, 9.4 %, and 10.9 %, respectively. Age (19-29 years), treatment setting (emergency and inpatient), and psychotropic medications were associated with conversion to BD across all precursor diagnoses. Severe and psychotic forms of MDD were among the strongest risk factors for transitioning to BD. Although risk factors for convertion were similar, transition rates were lower in children, particularly in indivudals with ADHD, who showed a higher rate of BD conversion in adults. CONCLUSIONS The highest risk of transitioning to BD was observed in patients initially diagnosed with MDD, though significant risk was also noted in those with initial diagnoses of anxiety disorders and adult ADHD.
Collapse
Affiliation(s)
- Kevin Li
- Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Katrina M Rodriguez
- Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, NY, New York, USA
| | - Peter Zandi
- Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | - Fernando S Goes
- Department of Psychiatry and Behavioral Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
| |
Collapse
|